Medical Devices

Global Liver Diseases Therapeutics Drugs Market Size, Status and Forecast 2018-2025

  • QYR2790503
  • 104 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
In 2017, the global Liver Diseases Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.

The key players covered in this study

F. Hoffmann-La Roche

Gilead Sciences

GlaxoSmithKline

Johnson & Johnson

Merck

Achillion Pharmaceuticals

AbbVie

Angion Biomedica

Bayer

LG Life Sciences

Phenex Pharmaceuticals

ProMetic Life Sciences

Raptor Pharmaceuticals

Shenzhen Kangtai Biological Products

Verva Pharmaceuticals

Market segment by Type, the product can be split into

Oral

Injection

Market segment by Application, split into

Hospitals

Clinics

Other

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.

To present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Liver Diseases Therapeutics Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type (2013-2025)

1.4.2 Oral

1.4.3 Injection

1.5 Market by Application

1.5.1 Global Liver Diseases Therapeutics Drugs Market Share by Application (2013-2025)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Liver Diseases Therapeutics Drugs Market Size

2.2 Liver Diseases Therapeutics Drugs Growth Trends by Regions

2.2.1 Liver Diseases Therapeutics Drugs Market Size by Regions (2013-2025)

2.2.2 Liver Diseases Therapeutics Drugs Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Liver Diseases Therapeutics Drugs Market Size by Manufacturers

3.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2013-2018)

3.1.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Liver Diseases Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Liver Diseases Therapeutics Drugs Key Players Head office and Area Served

3.3 Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service

3.4 Date of Enter into Liver Diseases Therapeutics Drugs Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018)

4.2 Global Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018)

5 United States

5.1 United States Liver Diseases Therapeutics Drugs Market Size (2013-2018)

5.2 Liver Diseases Therapeutics Drugs Key Players in United States

5.3 United States Liver Diseases Therapeutics Drugs Market Size by Type

5.4 United States Liver Diseases Therapeutics Drugs Market Size by Application

6 Europe

6.1 Europe Liver Diseases Therapeutics Drugs Market Size (2013-2018)

6.2 Liver Diseases Therapeutics Drugs Key Players in Europe

6.3 Europe Liver Diseases Therapeutics Drugs Market Size by Type

6.4 Europe Liver Diseases Therapeutics Drugs Market Size by Application

7 China

7.1 China Liver Diseases Therapeutics Drugs Market Size (2013-2018)

7.2 Liver Diseases Therapeutics Drugs Key Players in China

7.3 China Liver Diseases Therapeutics Drugs Market Size by Type

7.4 China Liver Diseases Therapeutics Drugs Market Size by Application

8 Japan

8.1 Japan Liver Diseases Therapeutics Drugs Market Size (2013-2018)

8.2 Liver Diseases Therapeutics Drugs Key Players in Japan

8.3 Japan Liver Diseases Therapeutics Drugs Market Size by Type

8.4 Japan Liver Diseases Therapeutics Drugs Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Liver Diseases Therapeutics Drugs Market Size (2013-2018)

9.2 Liver Diseases Therapeutics Drugs Key Players in Southeast Asia

9.3 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type

9.4 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application

10 India

10.1 India Liver Diseases Therapeutics Drugs Market Size (2013-2018)

10.2 Liver Diseases Therapeutics Drugs Key Players in India

10.3 India Liver Diseases Therapeutics Drugs Market Size by Type

10.4 India Liver Diseases Therapeutics Drugs Market Size by Application

11 Central & South America

11.1 Central & South America Liver Diseases Therapeutics Drugs Market Size (2013-2018)

11.2 Liver Diseases Therapeutics Drugs Key Players in Central & South America

11.3 Central & South America Liver Diseases Therapeutics Drugs Market Size by Type

11.4 Central & South America Liver Diseases Therapeutics Drugs Market Size by Application

12 International Players Profiles

12.1 F. Hoffmann-La Roche

12.1.1 F. Hoffmann-La Roche Company Details

12.1.2 Company Description and Business Overview

12.1.3 Liver Diseases Therapeutics Drugs Introduction

12.1.4 F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.1.5 F. Hoffmann-La Roche Recent Development

12.2 Gilead Sciences

12.2.1 Gilead Sciences Company Details

12.2.2 Company Description and Business Overview

12.2.3 Liver Diseases Therapeutics Drugs Introduction

12.2.4 Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.2.5 Gilead Sciences Recent Development

12.3 GlaxoSmithKline

12.3.1 GlaxoSmithKline Company Details

12.3.2 Company Description and Business Overview

12.3.3 Liver Diseases Therapeutics Drugs Introduction

12.3.4 GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.3.5 GlaxoSmithKline Recent Development

12.4 Johnson & Johnson

12.4.1 Johnson & Johnson Company Details

12.4.2 Company Description and Business Overview

12.4.3 Liver Diseases Therapeutics Drugs Introduction

12.4.4 Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.4.5 Johnson & Johnson Recent Development

12.5 Merck

12.5.1 Merck Company Details

12.5.2 Company Description and Business Overview

12.5.3 Liver Diseases Therapeutics Drugs Introduction

12.5.4 Merck Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.5.5 Merck Recent Development

12.6 Achillion Pharmaceuticals

12.6.1 Achillion Pharmaceuticals Company Details

12.6.2 Company Description and Business Overview

12.6.3 Liver Diseases Therapeutics Drugs Introduction

12.6.4 Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.6.5 Achillion Pharmaceuticals Recent Development

12.7 AbbVie

12.7.1 AbbVie Company Details

12.7.2 Company Description and Business Overview

12.7.3 Liver Diseases Therapeutics Drugs Introduction

12.7.4 AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.7.5 AbbVie Recent Development

12.8 Angion Biomedica

12.8.1 Angion Biomedica Company Details

12.8.2 Company Description and Business Overview

12.8.3 Liver Diseases Therapeutics Drugs Introduction

12.8.4 Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.8.5 Angion Biomedica Recent Development

12.9 Bayer

12.9.1 Bayer Company Details

12.9.2 Company Description and Business Overview

12.9.3 Liver Diseases Therapeutics Drugs Introduction

12.9.4 Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.9.5 Bayer Recent Development

12.10 LG Life Sciences

12.10.1 LG Life Sciences Company Details

12.10.2 Company Description and Business Overview

12.10.3 Liver Diseases Therapeutics Drugs Introduction

12.10.4 LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)

12.10.5 LG Life Sciences Recent Development

12.11 Phenex Pharmaceuticals

12.12 ProMetic Life Sciences

12.13 Raptor Pharmaceuticals

12.14 Shenzhen Kangtai Biological Products

12.15 Verva Pharmaceuticals

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Liver Diseases Therapeutics Drugs Key Market Segments

Table Key Players Liver Diseases Therapeutics Drugs Covered

Table Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type 2013-2025

Figure Oral Figures

Table Key Players of Oral

Figure Injection Figures

Table Key Players of Injection

Table Global Liver Diseases Therapeutics Drugs Market Size Growth by Application 2013-2025 (Million US$)

Figure Hospitals Case Studies

Figure Clinics Case Studies

Figure Other Case Studies

Figure Liver Diseases Therapeutics Drugs Report Years Considered

Table Global Liver Diseases Therapeutics Drugs Market Size 2013-2025 (Million US$)

Figure Global Liver Diseases Therapeutics Drugs Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2013-2025 (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2013-2018 (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Share by Regions 2013-2018

Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2013-2018

Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2018

Table Market Top Trends

Table Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2013-2018)

Figure Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers in 2018

Table Global Liver Diseases Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service

Table Date of Enter into Liver Diseases Therapeutics Drugs Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Size Share by Type (2013-2018)

Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type (2013-2018)

Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Global Liver Diseases Therapeutics Drugs Market Size Share by Application (2013-2018)

Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Application (2013-2018)

Figure Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application in 2017

Figure United States Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table United States Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table United States Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table United States Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table United States Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table United States Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table United States Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure Europe Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Europe Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Europe Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table Europe Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Europe Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table Europe Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Europe Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure China Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table China Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table China Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table China Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table China Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table China Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table China Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure Japan Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Japan Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Japan Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table Japan Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Japan Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table Japan Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Japan Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure India Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table India Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table India Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table India Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table India Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table India Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table India Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Figure Central & South America Liver Diseases Therapeutics Drugs Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Liver Diseases Therapeutics Drugs Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Liver Diseases Therapeutics Drugs Market Share (2017-2018)

Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)

Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Type (2013-2018)

Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)

Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Application (2013-2018)

Table F. Hoffmann-La Roche Company Details

Table F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018) (Million US$)

Figure F. Hoffmann-La Roche Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table F. Hoffmann-La Roche Recent Development

Table Gilead Sciences Company Details

Table Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Gilead Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Gilead Sciences Recent Development

Table GlaxoSmithKline Company Details

Table GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure GlaxoSmithKline Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table GlaxoSmithKline Recent Development

Table Johnson & Johnson Company Details

Table Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Johnson & Johnson Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Johnson & Johnson Recent Development

Table Merck Company Details

Table Merck Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Merck Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Merck Recent Development

Table Achillion Pharmaceuticals Company Details

Table Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Achillion Pharmaceuticals Recent Development

Table AbbVie Company Details

Table AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure AbbVie Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table AbbVie Recent Development

Table Angion Biomedica Company Details

Table Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Angion Biomedica Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Angion Biomedica Recent Development

Table Bayer Company Details

Table Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure Bayer Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table Bayer Recent Development

Table LG Life Sciences Company Details

Table LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2013-2018)(Million US$)

Figure LG Life Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2013-2018)

Table LG Life Sciences Recent Development

Table Phenex Pharmaceuticals Company Details

Table ProMetic Life Sciences Company Details

Table Raptor Pharmaceuticals Company Details

Table Shenzhen Kangtai Biological Products Company Details

Table Verva Pharmaceuticals Company Details

Table Global Liver Diseases Therapeutics Drugs Market Size by Regions (Million US$) 2018-2025

Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions (2018-2025)

Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions in 2025

Figure United States Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Europe Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure China Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Japan Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure India Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Liver Diseases Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)

Table Global Liver Diseases Therapeutics Drugs Market Size by Product (2018-2025) (Million US$)

Figure Global Liver Diseases Therapeutics Drugs Market Size by Product (2018-2025)

Figure Global Liver Diseases Therapeutics Drugs Market Size by Product in 2025

Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2018-2025) (Million US$)

Figure Global Liver Diseases Therapeutics Drugs Market Size by Application (2018-2025)

Figure Global Liver Diseases Therapeutics Drugs Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370